Sveikatos atlasas - Company finances
|
EUR
|
2024
From: 2024-08-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|
|
Financial data
|
||
| Sales revenue | 6,712 | 28,915 |
| Profit before tax | -1,989 | 432 |
| Net profit | -1,989 | 406 |
| Equity | -1,909 | -1,503 |
| Liabilities | 4,385 | 1,946 |
| Non-current assets | 0 | 0 |
| Current assets | 2,476 | 443 |
| Total assets | 2,476 | 443 |
|
Financial indicators
|
||
| Revenue change y/y | - | +330.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -80.3% | 91.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -29.6% | 1.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -29.6% | 1.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Sveikatos atlasas - Social security debts
The company had no debts to Sodra
Sveikatos atlasas - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Sveikatos atlasas is: 0 €
| From | To | Overdue, € |
|---|---|---|
| 2026-06-19 | 2026-09-02 | 0.03 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Sveikatos atlasas, MB (code 306965103) is a Small partnership engaged in medical specialists activities. In 2025, the company generated EUR 28.9K in revenue, up sharply from EUR 6.7K in 2024, when the reporting period covered 152 days. Over the latest full year, net profit reached EUR 406 after a net loss of EUR 2.0K in 2024. Profitability improved materially, with the profit margin moving from -29.6% to 1.4%. The two-year trajectory shows a clear turnaround from loss-making activity to a modest profit in 2025.
The balance sheet remains very small. At the end of 2025, total assets were EUR 443, compared with EUR 2.5K a year earlier. Equity stayed negative at EUR -1.5K, while liabilities amounted to EUR 1.9K; in 2024, liabilities were EUR 4.4K and equity EUR -1.9K. Because the asset and equity base is very small and equity remains negative, return ratios and leverage indicators should be interpreted cautiously. Revenue relative to assets was very strong in 2025, reflecting a high turnover level rather than a large asset base.
The balance sheet remains very small. At the end of 2025, total assets were EUR 443, compared with EUR 2.5K a year earlier. Equity stayed negative at EUR -1.5K, while liabilities amounted to EUR 1.9K; in 2024, liabilities were EUR 4.4K and equity EUR -1.9K. Because the asset and equity base is very small and equity remains negative, return ratios and leverage indicators should be interpreted cautiously. Revenue relative to assets was very strong in 2025, reflecting a high turnover level rather than a large asset base.